These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 23910792)

  • 1. Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes.
    Zarchi O; Carmel M; Avni C; Attias J; Frisch A; Michaelovsky E; Patya M; Green T; Weinberger R; Weizman A; Gothelf D
    J Psychiatr Res; 2013 Nov; 47(11):1623-9. PubMed ID: 23910792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.
    Carmel M; Zarchi O; Michaelovsky E; Frisch A; Patya M; Green T; Gothelf D; Weizman A
    J Psychiatr Res; 2014 Sep; 56():28-35. PubMed ID: 24853458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia.
    Zinkstok J; Schmitz N; van Amelsvoort T; Moeton M; Baas F; Linszen D
    Genes Brain Behav; 2008 Feb; 7(1):61-9. PubMed ID: 17504246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome.
    Prasad SE; Howley S; Murphy KC
    Dev Disabil Res Rev; 2008; 14(1):26-34. PubMed ID: 18636634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome.
    de Koning MB; van Duin ED; Boot E; Bloemen OJ; Bakker JA; Abel KM; van Amelsvoort TA
    Psychopharmacology (Berl); 2015 Sep; 232(17):3111-22. PubMed ID: 26068888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COMT Val108/158 Met modifies mismatch negativity and cognitive function in 22q11 deletion syndrome.
    Baker K; Baldeweg T; Sivagnanasundaram S; Scambler P; Skuse D
    Biol Psychiatry; 2005 Jul; 58(1):23-31. PubMed ID: 15935994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catechol-o-methyltransferase (COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression.
    Tunbridge E; Burnet PW; Sodhi MS; Harrison PJ
    Synapse; 2004 Feb; 51(2):112-8. PubMed ID: 14618678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between a common haplotype in the COMT gene region and psychiatric disorders in individuals with 22q11.2DS.
    Michaelovsky E; Gothelf D; Korostishevsky M; Frisch A; Burg M; Carmel M; Steinberg T; Inbar D; Apter A; Weizman A
    Int J Neuropsychopharmacol; 2008 May; 11(3):351-63. PubMed ID: 17949513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study of polymorphisms in the alpha 7 nicotinic acetylcholine receptor subunit and catechol-o-methyl transferase genes with sensory gating in first-episode schizophrenia.
    Liu X; Hong X; Chan RC; Kong F; Peng Z; Wan X; Wang C; Cheng L
    Psychiatry Res; 2013 Oct; 209(3):431-8. PubMed ID: 23598060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Startle reactivity and prepulse inhibition of the acoustic startle response are modulated by catechol-O-methyl-transferase Val(158) Met polymorphism in adults with 22q11 deletion syndrome.
    de Koning MB; Boot E; Bloemen OJ; van Duin ED; Abel KM; de Haan L; Linszen DH; van Amelsvoort TA
    J Psychopharmacol; 2012 Dec; 26(12):1548-60. PubMed ID: 22952320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.
    Gothelf D; Law AJ; Frisch A; Chen J; Zarchi O; Michaelovsky E; Ren-Patterson R; Lipska BK; Carmel M; Kolachana B; Weizman A; Weinberger DR
    Biol Psychiatry; 2014 Mar; 75(5):406-13. PubMed ID: 23992923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of catechol-O-methyltransferase Val(108/158) Met genetic polymorphism with schizophrenia, P50 sensory gating, and negative symptoms in a Chinese population.
    Mao Q; Tan YL; Luo XG; Tian L; Wang ZR; Tan SP; Chen S; Yang GG; An HM; Yang FD; Zhang XY
    Psychiatry Res; 2016 Aug; 242():271-276. PubMed ID: 27315458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome.
    Monks S; Niarchou M; Davies AR; Walters JT; Williams N; Owen MJ; van den Bree MB; Murphy KC
    Schizophr Res; 2014 Mar; 153(1-3):231-6. PubMed ID: 24534796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia--relationship with COMT Val¹⁰⁸/¹⁵⁸Met polymorphism, gender and symptomatology.
    Boot E; Booij J; Abeling N; Meijer J; da Silva Alves F; Zinkstok J; Baas F; Linszen D; van Amelsvoort T
    J Psychopharmacol; 2011 Jul; 25(7):888-95. PubMed ID: 21447540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensory gating deficit is associated with catechol-O-methyltransferase polymorphisms in bipolar disorder.
    Ancín I; Cabranes JA; Vázquez-Álvarez B; Santos JL; Sánchez-Morla E; García-Jiménez MÁ; Fernández C; Barabash A
    World J Biol Psychiatry; 2011 Aug; 12(5):376-84. PubMed ID: 21595525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between autism spectrum disorder in individuals with velocardiofacial (22q11.2 deletion) syndrome and PRODH and COMT genotypes.
    Radoeva PD; Coman IL; Salazar CA; Gentile KL; Higgins AM; Middleton FA; Antshel KM; Fremont W; Shprintzen RJ; Morrow BE; Kates WR
    Psychiatr Genet; 2014 Dec; 24(6):269-72. PubMed ID: 25325218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia.
    Green MJ; Chia TY; Cairns MJ; Wu J; Tooney PA; Scott RJ; Carr VJ;
    J Psychiatr Res; 2014 Feb; 49():43-50. PubMed ID: 24252819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal cortical activation during response inhibition in 22q11.2 deletion syndrome.
    Gothelf D; Hoeft F; Hinard C; Hallmayer JF; Stoecker JV; Antonarakis SE; Morris MA; Reiss AL
    Hum Brain Mapp; 2007 Jun; 28(6):533-42. PubMed ID: 17427209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence for an effect of COMT Val158Met genotype on executive function in patients with 22q11 deletion syndrome.
    Glaser B; Debbane M; Hinard C; Morris MA; Dahoun SP; Antonarakis SE; Eliez S
    Am J Psychiatry; 2006 Mar; 163(3):537-9. PubMed ID: 16513880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between neurodevelopmental genes, neuroanatomy, and ultra high risk symptoms of psychosis in 22q11.2 deletion syndrome.
    Thompson CA; Karelis J; Middleton FA; Gentile K; Coman IL; Radoeva PD; Mehta R; Fremont WP; Antshel KM; Faraone SV; Kates WR
    Am J Med Genet B Neuropsychiatr Genet; 2017 Apr; 174(3):295-314. PubMed ID: 28139055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.